You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sorafenib

Showing 976 - 1000 of 1,094
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Renal Cell Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • Tucson, Arizona
  • +120 more
Jan 8, 2014

Refractory Chronic Lymphocytic Leukemia, Refractory Multiple Myeloma, Stage III Multiple Myeloma Trial in Rochester

Completed
  • Refractory Chronic Lymphocytic Leukemia
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Mar 18, 2013

Refractory Malignancy Trial in Nashville (Capecitabine and Sorafenib)

Completed
  • Refractory Malignancy
  • Capecitabine and Sorafenib
  • Nashville, Tennessee
    Tennessee Oncology, PLLC
Jan 31, 2013

Hepatocellular Carcinoma, Liver Cancer, Localized Unresectable Liver Cancer Trial in Philadelphia (sorafenib tosylate,

Completed
  • Hepatocellular Carcinoma
  • +2 more
  • sorafenib tosylate
  • +5 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Feb 25, 2013

Metastatic Renal Cell Carcinoma Trial in Kazan, Barnaul, Moscow (Everolimus)

Completed
  • Metastatic Renal Cell Carcinoma
  • Kazan, Tatarstan, Russian Federation
  • +2 more
Feb 5, 2014

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in San Antonio (drug,

Completed
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • sorafenib tosylate
  • +2 more
  • San Antonio, Texas
    Southwest Oncology Group
Feb 27, 2013

Refractory Multiple Myeloma Trial in San Antonio (sorafenib tosylate, laboratory biomarker analysis)

Completed
  • Refractory Multiple Myeloma
  • sorafenib tosylate
  • laboratory biomarker analysis
  • San Antonio, Texas
    Southwest Oncology Group
Jan 4, 2013

Kidney Cancer, Metastatic Cancer Trial in United States (sorafenib tosylate)

Completed
  • Kidney Cancer
  • Metastatic Cancer
  • sorafenib tosylate
  • Chicago, Illinois
  • +11 more
Feb 8, 2013

Stage III Melanoma, Stage IV Melanoma Trial in Bronx (sorafenib tosylate, laboratory biomarker analysis)

Completed
  • Stage III Melanoma
  • Stage IV Melanoma
  • sorafenib tosylate
  • laboratory biomarker analysis
  • Bronx, New York
    Montefiore Medical Center
Jan 14, 2013

Renal Cell Carcinoma Trial in Aurora (Erlotinib HCl, Sirolimus)

Completed
Has Results
  • Renal Cell Carcinoma
  • Aurora, Colorado
    University of Colorado Hospital
Mar 17, 2014

Metastatic Renal Cell Carcinoma Trial in United States (Ramucirumab)

Completed
Has Results
  • Metastatic Renal Cell Carcinoma
  • Ramucirumab
  • San Francisco, California
  • +10 more
May 16, 2014

Recurrent Renal Cell Cancer, Renal Cell Carcinoma, Stage III Renal Cell Cancer Trial in United States (etaracizumab,

Terminated
Has Results
  • Recurrent Renal Cell Cancer
  • +3 more
  • Marysville, California
  • +4 more
Apr 28, 2014

Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, Adenocarcinoma With Squamous Metaplasia of the

Completed
  • Adenocarcinoma of the Extrahepatic Bile Duct
  • +9 more
  • sorafenib tosylate
  • laboratory biomarker analysis
  • San Antonio, Texas
    Southwest Oncology Group
Jan 11, 2013

Pancreatic Cancer Trial in Barcelona, Madrid, Valencia (Gemcitabine, Radiotherapy, Sorafenib)

Completed
  • Pancreatic Cancer
  • Barcelona, Spain
  • +3 more
Nov 28, 2012

Advanced Cancers Trial (Curcumin, Sorafenib, Vorinostat)

Withdrawn
  • Advanced Cancers
  • (no location specified)
Oct 17, 2012

Anti-Vascular Endothelial Growth Factor Therapy in Advanced

Terminated
  • Hypertension
  • Proteinuria
    • Singapore, Singapore
      National University Hospital
    Dec 10, 2013

    Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment) Trial in

    Completed
    • Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment)
    • Barcelona, Spain
    • +9 more
    Nov 8, 2012

    Kidney Cancer, Metastatic Cancer Trial in Tours (drug, other, procedure)

    Unknown status
    • Kidney Cancer
    • Metastatic Cancer
    • antiangiogenesis therapy
    • +5 more
    • Tours, France
      Centre Hospitalier Universitaire Bretonneau de Tours
    Aug 9, 2013

    Colorectal Tumors Trial in Germany (Sorafenib, Placebo, Oxaliplatin or Irinotecan)

    Terminated
    • Colorectal Neoplasms
    • Sorafenib
    • +4 more
    • Pforzheim, Baden-Würtemberg, Germany
    • +56 more
    Mar 1, 2013

    Hepatocellular Carcinoma Trial in United States (mapatumumab, sorafenib)

    Completed
    • Hepatocellular Carcinoma
    • mapatumumab
    • sorafenib
    • Los Angeles, California
    • +5 more
    Oct 26, 2012

    Metastatic Malignant Melanoma Trial in San Francisco, Santa Monica (Avastin, Abraxane)

    Completed
    Has Results
    • Metastatic Malignant Melanoma
    • San Francisco, California
    • +1 more
    Jan 7, 2014

    the Treatment Hand-foot Syndrome Patients With Gastrointestinal Tumors or Breast Cancer, Who Are Treated With Capecitabine Trial

    No longer available
    • the Treatment Hand-foot Syndrome Patients With Gastrointestinal Tumors or Breast Cancer, Who Are Treated With Capecitabine
    • Mapisal
    • Urea hand-foot cream
    • Mannheim, Germany
      Universitätsmedizin Mannheim, III. Medizinische Klinik
    Oct 21, 2013

    Solid Tumors Trial in Houston (Dasatinib, Erlotinib, Lapatinib)

    Completed
    • Solid Tumors
    • Houston, Texas
      UT MD Anderson Cancer Center
    Oct 16, 2012

    Carcinoma, Hepatocellular Trial in Worldwide (sunitinib malate, sorafenib)

    Terminated
    Has Results
    • Carcinoma, Hepatocellular
    • sunitinib malate
    • sorafenib
    • Fountain Valley, California
    • +170 more
    Dec 7, 2012

    Liver Tumors Trial (Temsirolimus 25mg and Pegylated liposomal doxorubicin 25mg/m2)

    Withdrawn
    • Liver Neoplasms
    • Temsirolimus 25mg and Pegylated liposomal doxorubicin 25mg/m2
    • (no location specified)
    Jul 2, 2013